- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Monoclonal Antibody Medicine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report is a detailed and comprehensive analysis for global Monoclonal Antibody Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Monoclonal Antibody Medicine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Monoclonal Antibody Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Monoclonal Antibody Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Monoclonal Antibody Medicine market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Monoclonal Antibody Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Monoclonal Antibody Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Monoclonal Antibody Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biologics
Biosimilars
Market segment by Application
Cancer
Autoimmune Disease
Other
Market segment by players, this report covers
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Innovent Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Monoclonal Antibody Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Monoclonal Antibody Medicine, with revenue, gross margin and global market share of Monoclonal Antibody Medicine from 2018 to 2023.
Chapter 3, the Monoclonal Antibody Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Monoclonal Antibody Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Monoclonal Antibody Medicine.
Chapter 13, to describe Monoclonal Antibody Medicine research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Monoclonal Antibody Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Monoclonal Antibody Medicine by Type
1.3.1 Overview: Global Monoclonal Antibody Medicine Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Monoclonal Antibody Medicine Consumption Value Market Share by Type in 2022
1.3.3 Biologics
1.3.4 Biosimilars
1.4 Global Monoclonal Antibody Medicine Market by Application
1.4.1 Overview: Global Monoclonal Antibody Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer
1.4.3 Autoimmune Disease
1.4.4 Other
1.5 Global Monoclonal Antibody Medicine Market Size & Forecast
1.6 Global Monoclonal Antibody Medicine Market Size and Forecast by Region
1.6.1 Global Monoclonal Antibody Medicine Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Monoclonal Antibody Medicine Market Size by Region, (2018-2029)
1.6.3 North America Monoclonal Antibody Medicine Market Size and Prospect (2018-2029)
1.6.4 Europe Monoclonal Antibody Medicine Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Monoclonal Antibody Medicine Market Size and Prospect (2018-2029)
1.6.6 South America Monoclonal Antibody Medicine Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Monoclonal Antibody Medicine Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Monoclonal Antibody Medicine Product and Solutions
2.1.4 Roche Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Monoclonal Antibody Medicine Product and Solutions
2.2.4 Amgen Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments and Future Plans
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Monoclonal Antibody Medicine Product and Solutions
2.3.4 AbbVie Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AbbVie Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Monoclonal Antibody Medicine Product and Solutions
2.4.4 Sanofi Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Monoclonal Antibody Medicine Product and Solutions
2.5.4 Johnson & Johnson Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Monoclonal Antibody Medicine Product and Solutions
2.6.4 Pfizer Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Monoclonal Antibody Medicine Product and Solutions
2.7.4 Eli Lilly Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Eli Lilly Recent Developments and Future Plans
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Monoclonal Antibody Medicine Product and Solutions
2.8.4 Novartis Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Novartis Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Monoclonal Antibody Medicine Product and Solutions
2.9.4 Merck Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck Recent Developments and Future Plans
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business
2.10.3 Biogen Monoclonal Antibody Medicine Product and Solutions
2.10.4 Biogen Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biogen Recent Developments and Future Plans
2.11 Celltrion
2.11.1 Celltrion Details
2.11.2 Celltrion Major Business
2.11.3 Celltrion Monoclonal Antibody Medicine Product and Solutions
2.11.4 Celltrion Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Celltrion Recent Developments and Future Plans
2.12 Sobi
2.12.1 Sobi Details
2.12.2 Sobi Major Business
2.12.3 Sobi Monoclonal Antibody Medicine Product and Solutions
2.12.4 Sobi Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sobi Recent Developments and Future Plans
2.13 3SBIO
2.13.1 3SBIO Details
2.13.2 3SBIO Major Business
2.13.3 3SBIO Monoclonal Antibody Medicine Product and Solutions
2.13.4 3SBIO Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 3SBIO Recent Developments and Future Plans
2.14 Innovent Biologics
2.14.1 Innovent Biologics Details
2.14.2 Innovent Biologics Major Business
2.14.3 Innovent Biologics Monoclonal Antibody Medicine Product and Solutions
2.14.4 Innovent Biologics Monoclonal Antibody Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Innovent Biologics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Monoclonal Antibody Medicine Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Monoclonal Antibody Medicine by Company Revenue
3.2.2 Top 3 Monoclonal Antibody Medicine Players Market Share in 2022
3.2.3 Top 6 Monoclonal Antibody Medicine Players Market Share in 2022
3.3 Monoclonal Antibody Medicine Market: Overall Company Footprint Analysis
3.3.1 Monoclonal Antibody Medicine Market: Region Footprint
3.3.2 Monoclonal Antibody Medicine Market: Company Product Type Footprint
3.3.3 Monoclonal Antibody Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Monoclonal Antibody Medicine Consumption Value and Market Share by Type (2018-2023)
4.2 Global Monoclonal Antibody Medicine Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Monoclonal Antibody Medicine Consumption Value Market Share by Application (2018-2023)
5.2 Global Monoclonal Antibody Medicine Market Forecast by Application (2024-2029)
6 North America
6.1 North America Monoclonal Antibody Medicine Consumption Value by Type (2018-2029)
6.2 North America Monoclonal Antibody Medicine Consumption Value by Application (2018-2029)
6.3 North America Monoclonal Antibody Medicine Market Size by Country
6.3.1 North America Monoclonal Antibody Medicine Consumption Value by Country (2018-2029)
6.3.2 United States Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
6.3.3 Canada Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
6.3.4 Mexico Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Monoclonal Antibody Medicine Consumption Value by Type (2018-2029)
7.2 Europe Monoclonal Antibody Medicine Consumption Value by Application (2018-2029)
7.3 Europe Monoclonal Antibody Medicine Market Size by Country
7.3.1 Europe Monoclonal Antibody Medicine Consumption Value by Country (2018-2029)
7.3.2 Germany Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
7.3.3 France Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
7.3.5 Russia Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
7.3.6 Italy Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Monoclonal Antibody Medicine Market Size by Region
8.3.1 Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Region (2018-2029)
8.3.2 China Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
8.3.3 Japan Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
8.3.4 South Korea Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
8.3.5 India Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
8.3.7 Australia Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
9 South America
9.1 South America Monoclonal Antibody Medicine Consumption Value by Type (2018-2029)
9.2 South America Monoclonal Antibody Medicine Consumption Value by Application (2018-2029)
9.3 South America Monoclonal Antibody Medicine Market Size by Country
9.3.1 South America Monoclonal Antibody Medicine Consumption Value by Country (2018-2029)
9.3.2 Brazil Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
9.3.3 Argentina Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Monoclonal Antibody Medicine Market Size by Country
10.3.1 Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Country (2018-2029)
10.3.2 Turkey Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
10.3.4 UAE Monoclonal Antibody Medicine Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Monoclonal Antibody Medicine Market Drivers
11.2 Monoclonal Antibody Medicine Market Restraints
11.3 Monoclonal Antibody Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Monoclonal Antibody Medicine Industry Chain
12.2 Monoclonal Antibody Medicine Upstream Analysis
12.3 Monoclonal Antibody Medicine Midstream Analysis
12.4 Monoclonal Antibody Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibody Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Monoclonal Antibody Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Monoclonal Antibody Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Monoclonal Antibody Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Monoclonal Antibody Medicine Product and Solutions
Table 8. Roche Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Amgen Company Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Monoclonal Antibody Medicine Product and Solutions
Table 13. Amgen Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Amgen Recent Developments and Future Plans
Table 15. AbbVie Company Information, Head Office, and Major Competitors
Table 16. AbbVie Major Business
Table 17. AbbVie Monoclonal Antibody Medicine Product and Solutions
Table 18. AbbVie Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. AbbVie Recent Developments and Future Plans
Table 20. Sanofi Company Information, Head Office, and Major Competitors
Table 21. Sanofi Major Business
Table 22. Sanofi Monoclonal Antibody Medicine Product and Solutions
Table 23. Sanofi Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sanofi Recent Developments and Future Plans
Table 25. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 26. Johnson & Johnson Major Business
Table 27. Johnson & Johnson Monoclonal Antibody Medicine Product and Solutions
Table 28. Johnson & Johnson Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Johnson & Johnson Recent Developments and Future Plans
Table 30. Pfizer Company Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Monoclonal Antibody Medicine Product and Solutions
Table 33. Pfizer Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pfizer Recent Developments and Future Plans
Table 35. Eli Lilly Company Information, Head Office, and Major Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Monoclonal Antibody Medicine Product and Solutions
Table 38. Eli Lilly Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Eli Lilly Recent Developments and Future Plans
Table 40. Novartis Company Information, Head Office, and Major Competitors
Table 41. Novartis Major Business
Table 42. Novartis Monoclonal Antibody Medicine Product and Solutions
Table 43. Novartis Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Novartis Recent Developments and Future Plans
Table 45. Merck Company Information, Head Office, and Major Competitors
Table 46. Merck Major Business
Table 47. Merck Monoclonal Antibody Medicine Product and Solutions
Table 48. Merck Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck Recent Developments and Future Plans
Table 50. Biogen Company Information, Head Office, and Major Competitors
Table 51. Biogen Major Business
Table 52. Biogen Monoclonal Antibody Medicine Product and Solutions
Table 53. Biogen Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Recent Developments and Future Plans
Table 55. Celltrion Company Information, Head Office, and Major Competitors
Table 56. Celltrion Major Business
Table 57. Celltrion Monoclonal Antibody Medicine Product and Solutions
Table 58. Celltrion Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Celltrion Recent Developments and Future Plans
Table 60. Sobi Company Information, Head Office, and Major Competitors
Table 61. Sobi Major Business
Table 62. Sobi Monoclonal Antibody Medicine Product and Solutions
Table 63. Sobi Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Sobi Recent Developments and Future Plans
Table 65. 3SBIO Company Information, Head Office, and Major Competitors
Table 66. 3SBIO Major Business
Table 67. 3SBIO Monoclonal Antibody Medicine Product and Solutions
Table 68. 3SBIO Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. 3SBIO Recent Developments and Future Plans
Table 70. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 71. Innovent Biologics Major Business
Table 72. Innovent Biologics Monoclonal Antibody Medicine Product and Solutions
Table 73. Innovent Biologics Monoclonal Antibody Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Innovent Biologics Recent Developments and Future Plans
Table 75. Global Monoclonal Antibody Medicine Revenue (USD Million) by Players (2018-2023)
Table 76. Global Monoclonal Antibody Medicine Revenue Share by Players (2018-2023)
Table 77. Breakdown of Monoclonal Antibody Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Monoclonal Antibody Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key Monoclonal Antibody Medicine Players
Table 80. Monoclonal Antibody Medicine Market: Company Product Type Footprint
Table 81. Monoclonal Antibody Medicine Market: Company Product Application Footprint
Table 82. Monoclonal Antibody Medicine New Market Entrants and Barriers to Market Entry
Table 83. Monoclonal Antibody Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Monoclonal Antibody Medicine Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global Monoclonal Antibody Medicine Consumption Value Share by Type (2018-2023)
Table 86. Global Monoclonal Antibody Medicine Consumption Value Forecast by Type (2024-2029)
Table 87. Global Monoclonal Antibody Medicine Consumption Value by Application (2018-2023)
Table 88. Global Monoclonal Antibody Medicine Consumption Value Forecast by Application (2024-2029)
Table 89. North America Monoclonal Antibody Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America Monoclonal Antibody Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America Monoclonal Antibody Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 92. North America Monoclonal Antibody Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 93. North America Monoclonal Antibody Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America Monoclonal Antibody Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe Monoclonal Antibody Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe Monoclonal Antibody Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe Monoclonal Antibody Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 98. Europe Monoclonal Antibody Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 99. Europe Monoclonal Antibody Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Monoclonal Antibody Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 104. Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 105. Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific Monoclonal Antibody Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America Monoclonal Antibody Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America Monoclonal Antibody Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America Monoclonal Antibody Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 110. South America Monoclonal Antibody Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 111. South America Monoclonal Antibody Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America Monoclonal Antibody Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 116. Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 117. Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa Monoclonal Antibody Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 119. Monoclonal Antibody Medicine Raw Material
Table 120. Key Suppliers of Monoclonal Antibody Medicine Raw Materials
List of Figures
Figure 1. Monoclonal Antibody Medicine Picture
Figure 2. Global Monoclonal Antibody Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Monoclonal Antibody Medicine Consumption Value Market Share by Type in 2022
Figure 4. Biologics
Figure 5. Biosimilars
Figure 6. Global Monoclonal Antibody Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Monoclonal Antibody Medicine Consumption Value Market Share by Application in 2022
Figure 8. Cancer Picture
Figure 9. Autoimmune Disease Picture
Figure 10. Other Picture
Figure 11. Global Monoclonal Antibody Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Monoclonal Antibody Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Monoclonal Antibody Medicine Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Monoclonal Antibody Medicine Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Monoclonal Antibody Medicine Consumption Value Market Share by Region in 2022
Figure 16. North America Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Monoclonal Antibody Medicine Revenue Share by Players in 2022
Figure 22. Monoclonal Antibody Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Monoclonal Antibody Medicine Market Share in 2022
Figure 24. Global Top 6 Players Monoclonal Antibody Medicine Market Share in 2022
Figure 25. Global Monoclonal Antibody Medicine Consumption Value Share by Type (2018-2023)
Figure 26. Global Monoclonal Antibody Medicine Market Share Forecast by Type (2024-2029)
Figure 27. Global Monoclonal Antibody Medicine Consumption Value Share by Application (2018-2023)
Figure 28. Global Monoclonal Antibody Medicine Market Share Forecast by Application (2024-2029)
Figure 29. North America Monoclonal Antibody Medicine Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Monoclonal Antibody Medicine Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Monoclonal Antibody Medicine Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Monoclonal Antibody Medicine Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Monoclonal Antibody Medicine Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Monoclonal Antibody Medicine Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 39. France Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Monoclonal Antibody Medicine Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Monoclonal Antibody Medicine Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Monoclonal Antibody Medicine Consumption Value Market Share by Region (2018-2029)
Figure 46. China Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 49. India Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Monoclonal Antibody Medicine Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Monoclonal Antibody Medicine Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Monoclonal Antibody Medicine Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Monoclonal Antibody Medicine Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Monoclonal Antibody Medicine Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Monoclonal Antibody Medicine Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Monoclonal Antibody Medicine Consumption Value (2018-2029) & (USD Million)
Figure 63. Monoclonal Antibody Medicine Market Drivers
Figure 64. Monoclonal Antibody Medicine Market Restraints
Figure 65. Monoclonal Antibody Medicine Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Monoclonal Antibody Medicine in 2022
Figure 68. Manufacturing Process Analysis of Monoclonal Antibody Medicine
Figure 69. Monoclonal Antibody Medicine Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
